A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a ...

Conclusion: Several inhaled insulin products are under development ... [1] Depending on the severity of the disease, patients often require three or more insulin injections daily to control ...

Clinical programs for inhaled insulin have received several setbacks of late, with Bagsværd, Denmark-based Novo Nordisk deciding in January to terminate phase 3 trials of its inhaler and ...

Exclusion criteria included poorly controlled asthma, chronic obstructive pulmonary disease or other significant ... the 2 months before screening or inhaled insulin in any clinical trial; and ...

“Inhalers are prime examples, like insulin, of products where manufacturers ... our medicines to help patients living with ...

“Exubera, the first inhaled form of insulin ... all by people with unstable or poorly controlled lung disease. As with all forms of insulin, a possible side effect of Exubera is low blood ...

However, the market for all inhalation-related diseases, specifically idiopathic ... not hindered by the withdrawal of the first inhaled insulin, Exubera, in 2007. In fact over the past four ...

Doctors battling diabetes across the Middle East have welcomed the decision by the Ministry of Health (MOH) in the UAE to approve the registration of an insulin inhalation treatment seen as a ...

The hand-held Exubera inhaler is a rapid-acting, dry powder human insulin that is inhaled through the mouth prior to eating. It weighs four ounces and, when closed, is about the size of an ...

“In theory, inhaled insulin completely eliminated the psychological ... chronic obstructive pulmonary disease (COPD) or smoking habits. “It may be a cause for concern in many Indian cities ...

"Until today, patients with diabetes who need insulin to manage their disease had only one way to ... "It is our hope the availability of inhaled insulin will offer patients more options to ...

Endocrine Diseases for MannKind Corporation. “It was exciting to partner with MannKind and help lead this study to potentially expand the use of inhaled insulin, which is currently used ...